scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0002-9440(10)64884-5 |
P8608 | Fatcat ID | release_kr7el3bemva27ghmi3ry2gmqwe |
P932 | PMC publication ID | 1850631 |
P698 | PubMed publication ID | 11839585 |
P50 | author | Mark D. Gorrell | Q38799589 |
Catherine Anne Abbott | Q39188539 | ||
Geoffrey W McCaughan | Q93355454 | ||
Nicholas A Shackel | Q115135167 | ||
P2093 | author name string | Peter H McGuinness | |
P2860 | cites work | Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium | Q22009003 |
Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver | Q22010826 | ||
Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors | Q24309604 | ||
SARPs: a family of secreted apoptosis-related proteins | Q24311564 | ||
Signal transduction by the Wnt family of ligands | Q24530639 | ||
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions | Q24564834 | ||
A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors | Q24569584 | ||
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers | Q27485114 | ||
Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model | Q28142724 | ||
Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer | Q28286663 | ||
The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily | Q28304981 | ||
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice | Q29620765 | ||
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C | Q29620791 | ||
Options available--from start to finish--for obtaining expression data by microarray. | Q31920702 | ||
The role of hepatitis C virus in hepatocellular carcinoma | Q33534995 | ||
DNA microarray technology: the anticipated impact on the study of human disease | Q33600666 | ||
Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. | Q33720363 | ||
Apoptosis and pathogenesis of viral hepatitis C--an update | Q33886610 | ||
Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. | Q33916624 | ||
Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection | Q35358973 | ||
Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression | Q35365390 | ||
Cellular and molecular mechanisms of hepatocarcinogenesis | Q35532421 | ||
Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array | Q38330139 | ||
Co-localisation of insulin-like growth factor II and the proliferation marker MIB1 in hepatocellular carcinoma cells | Q38475539 | ||
Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation | Q38477912 | ||
Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines | Q38506378 | ||
Expression of connective tissue growth factor in experimental rat and human liver fibrosis | Q40926848 | ||
Cell surface immunophenotype and gelatinase activity of the human breast carcinoma cell line (MCF-7/6) with functionally defective E-cadherin. | Q40950970 | ||
Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. | Q40983568 | ||
Wnt signalling goes nuclear | Q41359112 | ||
Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer | Q41842388 | ||
CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver. | Q42993011 | ||
c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma | Q43526977 | ||
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. | Q43623003 | ||
The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo | Q44383140 | ||
Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. | Q45765597 | ||
Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes | Q46371284 | ||
Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. | Q47872924 | ||
Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma | Q47912418 | ||
Application of the differential hybridization of Atlas Human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue | Q48473627 | ||
Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: an immunohistochemical study. | Q50950759 | ||
A DNA chip off the aging block. | Q51604342 | ||
Frzb-1, an antagonist of Wnt-1 and Wnt-8, does not block signaling by Wnts -3A, -5A, or -11. | Q52193425 | ||
Fas system and apoptosis in viral hepatitis. | Q53961575 | ||
cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines. | Q55476928 | ||
Oncostatin M: a cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells | Q60537831 | ||
Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis | Q60617867 | ||
Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas | Q71173348 | ||
Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor | Q71381389 | ||
Molecular dissection of the mitogenic effect of hepatocytes on cultured hepatic stellate cells | Q71818782 | ||
Histological patterns of prolonged hepatitis C infection | Q72898849 | ||
Pathogenesis of liver fibrosis | Q73129364 | ||
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis | Q73136433 | ||
Differential gene expression between chronic hepatitis B and C hepatic lesion | Q73570992 | ||
Characterization and regulation of insulin-like growth factor binding proteins in human hepatic stellate cells | Q74038832 | ||
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma | Q74093462 | ||
Characterization of the IGF axis components in isolated rat hepatic stellate cells | Q74530388 | ||
Serum levels of soluble Fas antigen in chronic hepatitis C patients | Q77585915 | ||
Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells | Q77598562 | ||
T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density | Q77756341 | ||
Chronically elevated proliferation as a risk factor for neoplasia | Q77783869 | ||
Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells | Q93890819 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virology | Q7215 |
liver cirrhosis | Q147778 | ||
hepatitis C | Q154869 | ||
Hepatitis C virus | Q708693 | ||
P304 | page(s) | 641-54 | |
P577 | publication date | 2002-02-01 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis | |
P478 | volume | 160 |
Q35749152 | Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis |
Q38376179 | Activation of Type I and Type III Interferons in Chronic Hepatitis C. |
Q36551170 | Activation of sonic hedgehog signaling pathway is an independent potential prognosis predictor in human hepatocellular carcinoma patients |
Q37607343 | Advances in viral hepatitis: 50 years of Australian gastroenterology |
Q46169180 | An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis |
Q42984532 | Analysis of gene transcription in sera during chronic hepatitis C infection. |
Q35762577 | Angiogenesis in chronic inflammatory liver disease |
Q36436755 | Angiogenic cell therapy for hepatic fibrosis |
Q94314421 | Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular Carcinomas |
Q36067494 | Association of differentially expressed genes with activation of mouse hepatic stellate cells by high-density cDNA microarray |
Q37409999 | Basic concepts of microarrays and potential applications in clinical microbiology |
Q91767797 | CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury |
Q53661342 | CD147 renal expression as a biomarker for progressive IgAN. |
Q45396613 | Changes in intrahepatic gene expression profiles from chronic hepatitis to hepatocellular carcinoma in patients with hepatitis C virus infection |
Q38157936 | Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations |
Q47411490 | Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1. |
Q50075361 | Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease |
Q94593890 | Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers |
Q37719732 | Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics |
Q24682975 | Dealing with the family: CD147 interactions with cyclophilins |
Q37261192 | Differences in gene expression profiles from asbestos-treated SPARC-null and wild-type mouse lungs |
Q40221690 | Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. |
Q37006700 | Differentially regulated gene expression associated with hepatitis C virus clearance |
Q35453802 | Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus |
Q34760613 | Discoidin domain receptor 1: isoform expression and potential functions in cirrhotic human liver. |
Q47387960 | Disease- and cell-specific expression of GP73 in human liver disease |
Q46843790 | Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis |
Q33832050 | ENCODE tiling array analysis identifies differentially expressed annotated and novel 5' capped RNAs in hepatitis C infected liver |
Q37057685 | Emmprin and KSHV: new partners in viral cancer pathogenesis. |
Q36962774 | Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment |
Q39018781 | Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma |
Q54776431 | Extracellular matrix metalloproteinase inducer is increased in smokers' bronchoalveolar lavage fluid. |
Q40370679 | Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line |
Q35666213 | Fibrosis progression in chronic hepatitis C virus infection |
Q35945962 | Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray |
Q35843317 | Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver |
Q38323133 | Gene network profiling before and after transplantation in alcoholic cirrhosis liver transplant recipients |
Q44804223 | Gene profiling of early and advanced liver disease in chronic hepatitis C patients |
Q80353336 | Genetics of hepatocellular carcinoma |
Q64105965 | Gexia-Zhuyu Decoction Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice Partly via Liver Angiogenesis Mediated by Myeloid Cells |
Q27488251 | HCV Tumor Promoting Effect Is Dependent on Host Genetic Background |
Q33946682 | Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation |
Q29616840 | Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver |
Q38337047 | Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses |
Q39563323 | Hepatitis C virus core protein promotes the migration and invasion of hepatocyte via activating transcription of extracellular matrix metalloproteinase inducer |
Q31126487 | Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis |
Q36749431 | Hepatitis C virus infection--pathobiology and implications for new therapeutic options |
Q34974042 | Hepatitis C virus virology and new treatment targets |
Q36561567 | Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies |
Q35373019 | Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis. |
Q33976028 | Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis |
Q40211269 | Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C. |
Q37997024 | Innate immunity and hepatitis C virus infection: a microarray's view |
Q36160709 | Insulin resistance and steatosis in hepatitis C virus infection. |
Q37788976 | Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. |
Q35994924 | Interferon alpha and T-cell responses in chronic myeloid leukemia |
Q34328120 | Interferon type I gene expression in chronic hepatitis C. |
Q43692671 | Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes |
Q35078322 | Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples |
Q27335708 | Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis |
Q33959178 | Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. |
Q35196596 | Molecular viral oncology of hepatocellular carcinoma |
Q26851211 | Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development |
Q61895898 | Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C |
Q46000902 | Overexpression of beta-catenin is responsible for the development of portal hypertension during liver cirrhosis. |
Q34936128 | Pathogenesis of hepatitis C virus recurrence in the liver allograft |
Q35046563 | Pathogenic interactions between alcohol and hepatitis C. |
Q34794004 | Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list. |
Q51841156 | Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. |
Q40371810 | Role for hedgehog signaling in hepatic stellate cell activation and viability |
Q37228554 | Role of emmprin/CD147 in tissue remodeling. |
Q38304391 | Role of signal transducer and activator of transcription 3 in liver fibrosis progression in chronic hepatitis C-infected patients |
Q54792449 | SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. |
Q24318809 | Sensing extracellular matrix: an update on discoidin domain receptor function |
Q35078725 | TP53 and liver carcinogenesis. |
Q36777331 | TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer |
Q37978104 | Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma |
Q33578091 | The Stimulation of CD147 Induces MMP-9 Expression through ERK and NF-kappaB in Macrophages: Implication for Atherosclerosis |
Q27008819 | The effect of physiological stimuli on sarcopenia; impact of Notch and Wnt signaling on impaired aged skeletal muscle repair |
Q36647336 | The hepatic transcriptome in human liver disease |
Q36812745 | Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer |
Q90382694 | δ-Tocotrienol feeding modulates gene expression of EIF2, mTOR, protein ubiquitination through multiple-signaling pathways in chronic hepatitis C patients |